We are live on ! Find out more
CEL

Cellcom Israel, Ltd.
CEL

Delisted

CEL was delisted on the 8th of February, 2021.

38 hedge funds and large institutions have $72.6M invested in Cellcom Israel, Ltd. in 2017 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 10 increasing their positions, 9 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 9

3% less funds holding

Funds holding: 3938 (-1)

14% less capital invested

Capital invested by funds: $84.7M → $72.6M (-$12.1M)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

Holders
38
Holders Change
-1
Holders Change %
-2.56%
% of All Funds
0.95%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
10
Reduced
9
Closed
3
Calls
$1.21M
Puts
Net Calls
+$1.21M
Net Calls Change
-$320K

CEL Hedge Fund Activity: Q2 2017 in Review

38 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Cellcom Israel, Ltd. (CEL) for Q2 2017, worth a combined $72.6M — down 14% from $84.7M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of CEL and 2 opened new positions — a net loss of 1 holder — while 9 trimmed existing stakes and 10 added.

The largest buyer was Vanguard Group, adding an estimated $801K. The largest seller was JP Morgan Chase, cutting an estimated $6.54M.

  • 38 institutional investors held Cellcom Israel, Ltd. (CEL) as of Q2 2017, down from 39 in Q1 2017.
  • Funds reported $72.6M of Cellcom Israel, Ltd. stock for Q2 2017, down 14% quarter-over-quarter.
  • 2 funds opened new Cellcom Israel, Ltd. positions in Q2 2017 and 3 closed out, a net change of -1 holder.
  • The largest Cellcom Israel, Ltd. buyer in Q2 2017 was Vanguard Group, an estimated $801K added.
  • The largest Cellcom Israel, Ltd. seller in Q2 2017 was JP Morgan Chase, an estimated $6.54M sold.

Based on aggregated 13F filings for Q2 2017.